Skip to main content
HALO logo

HALO · Halozyme Therapeutics, Inc.

Track HALO — free
Market Cap
$12.37B
Shares
113.50M

Debt Profile

Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.

Coverage backlog: 44 eligible filings and 0 covenant artifacts have no current-version terminal extraction result. This includes untouched sources and sources on the retry ladder.
No terminal debt extraction result is available yet; this is not evidence that the company has no debt.
Key facts CIK 1159036 CUSIP 40637H109 13F (30d) 407 filings 386 filers Visit website Investor relations